CLINICAL OUTCOMES OF AMMONIUM LACTATE 12% IN PATIENTS WITH SEVERE XEROSIS & KERATOSIS PILARIS: A CASE SERIES

Xerosis, characterized by dry, rough, and scaly skin, and keratosis pilaris (KP), identied by small, rough bumps, signicantly impact skin health and quality of life. This study evaluates the safety and efcacy of Lacderm® Lotion (ammonium lactate 12%) in treating these conditions. The study enrolled three patients presenting with symptoms of xerosis or KP. Treatments included Lacderm Lotion applied either once or twice daily, combined with adjunct therapies such as chemical peels, laser-based treatments, and SPF 50 sunscreen. Over a three-month period, signicant improvements in hydration, skin texture, and reduction of symptoms such as itching, scaling, and roughness were observed. Lacderm Lotion's dual action as a humectant and exfoliant demonstrated its efcacy in alleviating the symptoms of xerosis and KP, restoring the skin's natural barrier and preventing recurrences. This non-greasy formulation enhances adherence and ensures long-term benets, making it a well-tolerated option for managing these conditions